Paul Hastings (Nkarta)

‘You have to get up on the podi­um’: In­com­ing BIO chair Paul Hast­ings on di­ver­si­ty, drug pric­ing and work­ing with the FDA

Paul Hast­ings’ day job as CEO of Nkar­ta has him talk­ing about nat­ur­al killer cells and their po­ten­tial ap­pli­ca­tions in can­cer. But through­out the pan­dem­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.